Hannes Michel Wiesner1, Elton Tadeu Montrazi2, Tao Wang1, Kelsey Haney1, Xiao-Hong Zhu1, Lucio Frydman2, and Wei Chen1
1CMRR, Department of Radiology, University of Minnesota, Minneapolis, MN, United States, 2Weizmann, Rehovot, Israel
Synopsis
Keywords: Deuterium, Deuterium, DMI,MRSI,SSFP
Motivation: DMI's faces a poor SNR, and the detection of vital Glx/lactate metabolites in the brain tumor can be compromised.
Goal(s): This research aims to determine whether the optimized CSI-SSFP imaging method is effective for detecting the four biomarkers (HDO, Glucose, Glx, and Lactate) with improved SNR compared to traditional CSI in rodent brains.
Approach: The approach involves comparing DMI SNR using both traditional CSI and CSI-SSFP for monitoring and imaging the metabolism of injected [6,6’-2H2]-glucose in healthy mouse brains.
Results: CSI-SSFP highlights substantial enhancement of 2-3 times in SNR for Glx and lactate.
Impact: DMI is promising to
assess the Warburg effect associated with cancer. The CSI-SSFP method provides several
folds of SNR improvement, which is critical to improve sensitivity and
resolution aiming for imaging intra-tumor heterogeneity and metabolic
reprograming in brain tumors.
INTRODUCTION
Deuterium Metabolic Imaging (DMI) holds a great
potential for investigating cellular energy metabolism and tumor abnormality.
In brain, it involves tracking the uptake of [6,6’-2H2]-glucose
and monitoring the metabolite production of glutamate and glutamine (Glx),
lactate, and HDO. This approach allows to map these metabolites, which has been
demonstrated in recent studies to be highly effective in “Warburg-effect”
contrasting of brain tumors [1-3]. However, DMI faces its primary challenge in
terms of relatively poor signal-to-noise ratio (SNR), due to the low γ
(gyromagnetic ratio) of 2H spin and the low concentrations of
metabolic markers. Balanced Steady-State Free Precession (bSSFP) approaches can
enhance SNR by a factor of 2-3 when compared to conventional CSI methods, such
as the Ernst Angle condition or FID-SSFP condition, as recently demonstrated in
assessments of pancreatic cancer in mice [4-6]. For pancreatic cancer, only
three markers are detectable: HDO, Glucose, and Lactate. This study extends the
application of the CSI-SSFP sequence [6,7] for optimal detection of four
markers (HDO, Glucose, Glx and Lactate) in rodent brain at the ultrahigh field strength
of 16.4T.METHODS
In vivo experiments, approved by the University
of Minnesota IACUC, were conducted on healthy C57 black mice. DMI involved the
intraperitoneal (IP) injection of approximately 2.5 g/kg body weight of [6,6’-2H2]-glucose
in PBS, followed by the acquisition of 2H/1H images using
a 16.4T Bruker scanner equipped with a dual-frequency surface coil tuned to
697.54 MHz (1H) and 107.07 MHz (2H) [8]. Both
conventional 2H CSI with a repetition time (TR) of 62.5 ms and 2H
CSI-SSFP with TR=15.6 ms sequences were optimized for DMI with: flip angle of
60°, 16x16x5 matrices, and a field of view (FOV) of 18x18x15mm3.
Data acquisition involved sampling 300-point and 64-point gradient-free FIDs at
a rate of 5 kHz for CSI and CSI-SSFP, respectively.
CSI was performed with 24 weighted averages, 5 minutes per 3D volume, while
CSI-SSFP required 24 weighted averages and 4 repetitions (regular averaging),
totaling the same 5 minutes for acquisition. The two methods were acquired in an interleave way for a total experimental
duration of around 120 minutes.
Spatial domains were reconstructed
identically using 3D Fourier Transform (FT) after zero-filling to 64x64x5.
Images for CSI, derived from a 50 Hz spectrum integral (after FT of the FIDs)
for each metabolite, and CSI-SSFP FID points were processed using IDEAL, as
described in references [4-5,9]. IDEAL isolated images of individual sites
based on a priori known chemical shift positions. SNR maps were generated by
subtracting the amplitude of each voxel from the mean noise level and dividing
it by the standard deviation of the noise. Noise was collected from a region of
interest (ROI) with no signal in the images.RESULTS & DISCUSSION
The effective Number of Signal Averages (NSA) in Fig. 1 (left
panel) demonstrates that an acquisition time longer than 7.8 ms is sufficient
to separate the four metabolites of interest using the IDEAL fitting method
[4,9]. By seeking an acquisition time that satisfies this condition and
minimizing the TR, we have determined that a TR of 15.6 ms and a carrier
frequency of 2.95 ppm represent an optimal combination to avoid stopbands for
all metabolites (Fig. 1, right panel).
Fig. 2 shows a 1H image obtained from a healthy
mouse brain, along with the DMI outcomes recorded at various time points
following the IP injection of [6,6’-2H2]-glucose, using
both CSI and CSI-SSFP techniques. It's important to highlight the significantly
enhanced SNR especially for Glx and lactate in the CSI-SSFP data.
The full dynamic dataset,
corresponding to Fig. 2, is presented in Fig. 3. The superior SNR
of CSI-SSFP for Glx and lactate is evident. Before injection, only HDO at
natural abundance is observed. Following the injection, glucose immediately
appears, with its intensity varying over time. Glx and lactate have a delayed
appearance, albeit with much lower intensity compared to glucose. HDO levels
steadily increase over the entire 2-hour measurement period. Glx and lactate
seem to begin decreasing after 60 minutes, with a more pronounced decline in
lactate.
Fig. 4
provides a summary of SNR for individual metabolites across the entire series
of time-incremented images, with a specific focus on a ROI, indicating a
SNR improvement of approximately 2-3 times.CONCLUSION
CSI-SSFP was quantitatively assessed in this mice
brain study following the injection of [6,6’-2H2]-glucose,
focusing on four metabolites of interest (HDO, Glucose, Glx, and Lactate). The
CSI-SSFP method demonstrates superior scanning efficiency and enables
substantial improvements in SNR. The most significant SNR enhancements were
observed, particularly for Glx and lactate, which are crucial metabolites for cancer
detection.Acknowledgements
This work was supported
in part by NIH grants of R01 CA240953, R01 NS133006, U01 EB026978, S10
OD028712, P41 EB027061, and in part by the Minerva, the Israel Science
Foundation, and the Israel Cancer Research Foundation. LF heads the Clore
Institute for High-Field Magnetic Resonance Imaging and Spectroscopy, whose
support is also acknowledged.References
1. Lu M, Zhu
XH, Zhang Y, Low W, Chen W. Simultaneous Assessment of Abnormal Glycolysis and
Oxidative Metabolisms in Brain Tumor using In Vivo Deuterium MRS Imaging. Proc
Intl Soc Mag Reson Med; 2016; Singapore. p. 3962. https://cds.ismrm.org/protected/16MProceedings/PDFfiles/3962.html
2. Lu M, Zhu
XH, Zhang Y, Mateescu G, Chen W. Quantitative assessment of brain glucose
metabolic rates using in vivo deuterium magnetic resonance spectroscopy. J
Cereb Blood Flow Metab. 2017 Nov;37(11):3518-3530. doi: 10.1177/0271678X17706444.
Epub 2017 May 15. PMID: 28503999; PMCID: PMC5669347.
3. De Feyter
HM, Behar KL, Corbin ZA, Fulbright RK, Brown PB, McIntyre S, Nixon TW, Rothman
DL, de Graaf RA. Deuterium metabolic imaging (DMI) for MRI-based 3D mapping of
metabolism in vivo. Sci Adv. 2018 Aug 22;4(8):eaat7314. doi:
10.1126/sciadv.aat7314. PMID: 30140744; PMCID: PMC6105304.
4. Peters, DC,
Markovic, S, Bao, Q, et al. Improving deuterium metabolic imaging (DMI)
signal-to-noise ratio by spectroscopic multi-echo bSSFP: A pancreatic cancer
investigation. Magn Reson Med. 2021; 86: 2604– 2617.
https://doi.org/10.1002/mrm.28906
5. Montrazi ET,
Bao Q, Martinho RP, et al. Deuterium imaging of the Warburg effect at
sub-millimolar concentrations by joint processing of the kinetic and spectral
dimensions. NMR in Biomedicine. 2023; 36(11):e4995. doi:10.1002/nbm.4995
6. Montrazi ET,
Peters DC, Sasson K, Agemy L, Scherz A, and Frydman L. Improved Deuterium
Metabolic Imaging of Cancer by CSI-SSFP MRSI. ISMRM & ISMRT Annual Meeting
& Exhibition, 03-08 June 2023, Toronto, ON, Canada. https://cds.ismrm.org/protected/23MPresentations/abstracts/0016.html
7. Speck O,
Scheffler K, Hennig J. Fast 31P chemical shift imaging using SSFP
methods. Magn Reson Med. 2002 Oct;48(4):633-9. doi: 10.1002/mrm.10279. PMID:
12353280.
8. Zhang G, Zhu
W, Li X, Zhu XH, Chen W. Dual-frequency resonant coil design for low-γ
X-nuclear and proton magnetic resonance imaging at ultrahigh fields. NMR
Biomed. 2023 Aug;36(8):e4930. doi: 10.1002/nbm.4930. Epub 2023 Apr 18. PMID:
36939997.
9. Reeder SB,
Pineda AR, Wen Z, Shimakawa A, Yu H, Brittain JH, Gold GE, Beaulieu CH, Pelc
NJ. Iterative decomposition of water and fat with echo asymmetry and
least-squares estimation (IDEAL): application with fast spin-echo imaging. Magn
Reson Med. 2005 Sep;54(3):636-44. doi: 10.1002/mrm.20624. PMID: 16092103.